{"id":50720,"date":"2022-11-10T17:02:21","date_gmt":"2022-11-10T16:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/"},"modified":"2022-11-10T17:02:21","modified_gmt":"2022-11-10T16:02:21","slug":"iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/","title":{"rendered":"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel"},"content":{"rendered":"
\n

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA<\/a>\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a long-term collaboration with Clalit, the largest health services organization in Israel, to launch the first Prime Site in the country.\n<\/p>\n

<\/a><\/p>\n

\nThe collaboration combines IQVIA and Clalit\u2019s capabilities in clinical trial delivery, real-world research, data and genomics. Clalit operates a network of 14 hospitals and over 1600 primary care clinics. The health services organization provides full therapeutic coverage with significant expertise in, but not limited to, oncology, pediatric rare disease, and genomics. With this combined expertise, the collaboration will allow for focus on the future of innovation, including precision medicine and the delivery of data driven trials.\n<\/p>\n

\n\u201cIQVIA is excited to launch its first Prime Site in Israel with such an innovative and well-established healthcare organization as Clalit,\u201d said Alistair Grenfell, President, Europe, Middle East, Africa and South Asia, IQVIA. \u201cThe work done through this collaboration will transform healthcare and pharmaceutical research for Israel and the world, ultimately improving outcomes for patients.\u201d\n<\/p>\n

\nWith IQVIA\u2019s Connected Intelligence\u2122 and Clalit\u2019s mission to turn electronic medical records based data insights into improved policy and better healthcare, the collaboration ensures IQVIA can deliver on pharma interest in Israel as a premier destination for research and innovation. The Prime Site also ensures IQVIA can deliver an in-country solution to Israel pharma and biotech companies.\n<\/p>\n

\n“As the largest health organization in Israel, Clalit will now leverage its Prime Site designation to allow our patients access to the most advanced therapies being developed,\u201d said Mr. Eli Cohen, Acting General Director, Clalit Health Services. \u201cWe are thrilled to collaborate with IQVIA and increase their ability to do innovative healthcare research in Israel. Through utilization of data and strategic delivery of research and care, our work together will help unlock further understanding of pharmaceutical and healthcare developments in the real-world,\u201d he added.\n<\/p>\n

\nAbout IQVIA<\/b>\n<\/p>\n

\nIQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence\u2122 delivers powerful insights with speed and agility \u2014 enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 83,000 employees, IQVIA conducts operations in more than 100 countries.\n<\/p>\n

\nIQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA\u2019s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com<\/a>.\n<\/p>\n

\nAbout Clalit Health Services<\/b>\n<\/p>\n

\nClalit, the largest and leading payer-provider health organization in Israel, provides life-long inpatient and outpatient integrated medical services to more than 52% of the Israeli population. With over 1600 outpatient clinics throughout the country, 14 public hospitals, and an a wide variety of services through subsidiary companies – Clalit Smile dental clinics, Clalit Aesthetics, Clalit Complementary Medicine, and ‘Mor’ Medical Institutes and Services. As in innovation-driven organization, Clalit is globally recognized as forerunner in digital health and data-driven research and innovation hub, with special focus on proactive preventive care and illness promoting healthy lifestyle, with state-of-the-art services provided throughout the country – anywhere, anytime.\n<\/p>\n

\nFor more information: www.clalit.co.il<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNick Childs, IQVIA Investor Relations (nick.childs@iqvia.com<\/a>)
\n
+1.973.316.3828<\/p>\n

Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com<\/a>)
\n
+1.919.780.3221\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a long-term collaboration with Clalit, the largest health services organization in Israel, to launch the first Prime Site in the country. The collaboration combines IQVIA and Clalit\u2019s capabilities in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50720","6":"format-standard","7":"category-industry"},"yoast_head":"\nIQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a long-term collaboration with Clalit, the largest health services organization in Israel, to launch the first Prime Site in the country. The collaboration combines IQVIA and Clalit\u2019s capabilities in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-10T16:02:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221110005815\/en\/1633147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel\",\"datePublished\":\"2022-11-10T16:02:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/\"},\"wordCount\":660,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110005815\\\/en\\\/1633147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/\",\"name\":\"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110005815\\\/en\\\/1633147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"datePublished\":\"2022-11-10T16:02:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110005815\\\/en\\\/1633147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110005815\\\/en\\\/1633147\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/","og_locale":"en_US","og_type":"article","og_title":"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel - Pharma Trend","og_description":"RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA\u2122 (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a long-term collaboration with Clalit, the largest health services organization in Israel, to launch the first Prime Site in the country. The collaboration combines IQVIA and Clalit\u2019s capabilities in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-10T16:02:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221110005815\/en\/1633147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel","datePublished":"2022-11-10T16:02:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/"},"wordCount":660,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221110005815\/en\/1633147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/","url":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/","name":"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221110005815\/en\/1633147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","datePublished":"2022-11-10T16:02:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221110005815\/en\/1633147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221110005815\/en\/1633147\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/iqvia-and-clalit-health-services-partner-to-advance-research-by-launching-the-first-prime-site-in-israel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50720"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50720\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}